Pharmacogenomics of clopidogrel: evidence and perspectives
T Yin, T Miyata - Thrombosis research, 2011 - Elsevier
Clopidogrel has become the mainstay oral antiplatelet regimen to prevent recurrent
ischemic events after acute coronary syndromes or stent placement. However, there is …
ischemic events after acute coronary syndromes or stent placement. However, there is …
Pharmacogenomics of clopidogrel: Evidence and perspectives
T Yin, T Miyata - Thrombosis Research, 2011 - infona.pl
Clopidogrel has become the mainstay oral antiplatelet regimen to prevent recurrent
ischemic events after acute coronary syndromes or stent placement. However, there is …
ischemic events after acute coronary syndromes or stent placement. However, there is …
Pharmacogenomics of clopidogrel: evidence and perspectives.
T Yin, T Miyata - Thrombosis Research, 2011 - europepmc.org
Clopidogrel has become the mainstay oral antiplatelet regimen to prevent recurrent
ischemic events after acute coronary syndromes or stent placement. However, there is …
ischemic events after acute coronary syndromes or stent placement. However, there is …
Pharmacogenomics of clopidogrel: Evidence and perspectives
T Yin, T Miyata - Thrombosis Research, 2011 - thrombosisresearch.com
Clopidogrel has become the mainstay oral antiplatelet regimen to prevent recurrent
ischemic events after acute coronary syndromes or stent placement. However, there is …
ischemic events after acute coronary syndromes or stent placement. However, there is …
[引用][C] Pharmacogenomics of clopidogrel: Evidence and perspectives
T Yin, T Miyata - Thrombosis Research, 2011 - cir.nii.ac.jp
[引用][C] Pharmacogenomics of clopidogrel: Evidence and perspectives
T YIN, T MIYATA - Thrombosis research, 2011 - pascal-francis.inist.fr
Pharmacogenomics of clopidogrel: Evidence and perspectives CNRS Inist Pascal-Francis
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
Pharmacogenomics of clopidogrel: evidence and perspectives
T Yin, T Miyata - Thrombosis research, 2011 - pubmed.ncbi.nlm.nih.gov
Clopidogrel has become the mainstay oral antiplatelet regimen to prevent recurrent
ischemic events after acute coronary syndromes or stent placement. However, there is …
ischemic events after acute coronary syndromes or stent placement. However, there is …